Executives On The Move: Changes at the Top Ahead for Pfizer, New Division President at Bayer, and Advisors for VBI Vaccines.
Executive Summary
A change will kick off 2019 for Pfizer when it promotes its COO to CEO. Bayer has a new president, pharmaceuticals, Americas, while VBI Vaccines announces the formation of three scientific and clinical advisory boards.